Steven Carl Quay

Steven Carl Quay

Auto-generated profile, based on publicly available information

Steven Carl Quay

Atossa Therapeutics Inc., Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
HCHenry R. Costantino
Henry R. Costantino
LILisbeth Illum
Lisbeth Illum
GBGordon Brandt
Gordon Brandt
PJPaul H. Johnson
Paul H. Johnson
SQSteven C. Quay
Steven C. Quay

1 January 1990 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
WCWilliam P. Cacheris
William P. Cacheris
SQSteven C. Quay
Steven C. Quay
SRScott M. Rocklage
Scott M. Rocklage

22 May 1981 in Science
Verified
Journal Article
Closed access
PDF file
HDH. F. Dvorak
H. F. Dvorak
SQS. C. Quay
S. C. Quay
NON. S. Orenstein
N. S. Orenstein
ADA. M. Dvorak
A. M. Dvorak
PHP. Hahn
P. Hahn
ACA. C. Carvalho
A. C. Carvalho
Three syngeneic carcinomas from two species shed plasma membrane vesicles when cultured in vitro or grown in the ascites tumor form in vivo. Shed vesicles carry procoagulant activity that can account for the activation of the clotting system and the fibrin deposition associated with these and many other types of malignancy in animals and man.

1 January 1991 in Radiology
Verified
Journal Article
Closed access
GEG Elizondo
G Elizondo
CFC J Fretz
C J Fretz
DSD D Stark
D D Stark
SRS M Rocklage
S M Rocklage
SQS C Quay
S C Quay
JFJ T Ferrucci
J T Ferrucci
Manganese(II)-N,N'-dipyridoxylethylenediamine-N,N'-diacetate-5,5'-bis (phosphate) (MnDPDP) is a paramagnetic complex designed for use as a hepatobiliary agent. The T1 relaxivity of MnDPDP (2.8 [mmol/L]-1.sec-1 in aqueous solution) was similar to that of gadolinium diethylenetriaminepentaacetic acid (DTPA) (4.5 [mmol/L]-1.sec-1) and gadolinium tetraazocyclodecanetetraacetic acid (DOTA) (3.8 [mmol/L]-1.sec-1). However, in liver tissue the T1 relaxivity of MnDPDP (21.7 [mmol/L]-1.sec-1) was threefold higher than that reported for Gd-DOTA (6.7 [mmol/L]-1.sec-1). Maximum liver T1 relaxation enhancement occurred 30 minutes after injection of MnDPDP, at which time 54MnDPDP biodistribution studies indicated that 13% of total body activity was in the liver. Enhanced (MnDPDP, 50 mumol/kg) MR images showed a fivefold increase in tumor-liver contrast-to-noise ratio over baseline unenhanced images. Results of the authors' acute and subchronic toxicity studies suggest that MnDPDP will be safe at the doses necessary for clinical imaging; at 10 mumol/kg, the safety factor (LD50/effective dose) for MnDPDP is 540, significantly greater than the safety factor of Gd-DTPA (ie, 60-100).

1 January 1982 in Life Sciences
Verified
Journal Article
Closed access
RRRichard Re
Richard Re
John T. FallonJohn T. Fallon
John T. Fallon
VDVictor Dzau
Victor Dzau
SQSteven C. Quay
Steven C. Quay
EHEdgar Haber
Edgar Haber

1 September 1981 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CDC J Daniels
C J Daniels
DBD G Bole
D G Bole
SQS C Quay
S C Quay
DOD L Oxender
D L Oxender
The leucine-specific binding protein of E. coli is a periplasmic protein that is synthesized as a precursor and subsequently is processed during its secretion into the periplasmic space. The processing of both the leucine-specific binding protein and a plasmid-coded .beta.-lactamase is inhibited by phenethyl alcohol and by the proton ionophore, carbonylcyanide m-chlorophenylhydrazone (CCCP). The levels of CCCP that inhibit processing also produce significant decreases in the membrane potential. Valinomycin, a potassium ionophore, also inhibits processing of the leucine-specific binding protein in spheroplasts. Processing can be restored in CCCP-treated cells and in valinomycin-treated spheroplasts by dilution of the treated cells in fresh medium. Membrane potential apparently has a role in the secretion of periplasmic proteins. A model is presented which suggests that membrane potential plays a primary role in the proper orientation of the precursor signal sequence within the membrane, thus promoting processing and secretion.